<h2 id="Headline">
 Headline
</h2>
<h3 id="The_three_peptide_itch">
 The three-peptide itch
</h3>
<p>
 Just like pain, itch is a signal provided to our brain that something is wrong, or potentially dangerous. Contrary to pain, where our reflex leads to withdraw from danger, an itch leads to scratching, in order to remove the irritating, potentially toxic agent, be it an insect or a chemical. Although itching in response to environmental cues is crucial for survival, chronic itch can be debilitating and severely impact the well-being of affected persons. It is known that itch is relayed from the skin, via the dorsal root ganglion neurons, to the second order neurons in the spinal cord that project to the brain. Several
 <a href="http://www.uniprot.org/uniprot/?query=family:%22g-protein+coupled+receptor+1+family+mas+subfamily%22+organism:9606+AND+reviewed:yes">
  Mas-related G-protein coupled receptors
 </a>
 (MRGPRs) have been identified as the
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/29723501">
  primary targets of itch signals
 </a>
 , and many of them, including MRGPRX1 (also called MrgprC11 in rodents) and Mrgpra3, are activated by the anti-malarial drug chloroquine.
</p>
<p>
 However, the molecular and neural mechanisms of itch are not well elucidated, which is why the discovery of new tools to identify itch receptors and develop new drugs is extremely valuable. In this context,
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/10675883">
  conotoxins have proven to be a gold mine
 </a>
 . Conotoxins are produced by cone snails as part of an envenomation survival strategy for feeding and defense. They are short peptides (usually 10 to 30 amino acid residues), typically with one or more disulfide bonds. Many of them modulate the activity of ion channels and receptors with very high affinity and specificity. They can be highly selective between closely related receptor subtypes, therefore they could meet specific therapeutic needs with a reduced likelihood of side effects due to off-target drug effects.
</p>
<p>
 In mice, the injection of
 <a href="http://www.uniprot.org/taxonomy/6494">
  <em>
   Conus textile
  </em>
 </a>
 venom, but not that of
 <em>
  C. geographus
 </em>
 induced a scratching reflex, which was accompanied by the activation of
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/30243794">
  89% of sensory neurons that were also sensitive to chloroquine
 </a>
 . Two peptides, CNF-Tx1 and CNF-Tx2, were isolated from
 <em>
  C. textile
 </em>
 venom gland and tested
 <em>
  in vitro
 </em>
 for their activity on MRGPRX1. In parallel, the same activity was measured for two additional peptides, CNF-Sr1 and CNF-Sr2, previously identified in
 <a href="http://www.uniprot.org/taxonomy/192919">
  <em>
   C. spurious
  </em>
 </a>
 and one, CNF-Vc1, from
 <a href="http://www.uniprot.org/taxonomy/319920">
  <em>
   C. victoriae
  </em>
 </a>
 . Three of these peptides were able to activate MRGPRX1: CNF-Tx2 activated the human, but not the mouse ortholog, CNF-Sr1 activates only the mouse, but not the human ortholog, and CNF-Vc1 activated both. CNF-Tx2 and CNF-Vc1 were then tested in a humanized mouse transgenic line, which has a
 <a href="https://www.ncbi.nlm.nih.gov/pubmed/20004959">
  knockout of the entire endogenous MRGPR cluster
 </a>
 and expresses human MRGPRX1 in primary sensory neurons. In this setting, both peptides elicited a scratching reflex, further confirming that CNF-Tx2 and CNF-Vc1 act via the itch receptor MRGPRX1. Compared with the well-established MrgprX1 agonist chloroquine, CNF-Tx2 and CNF-Vc1 were 600 times and 200 times more potent, respectively.
</p>
<p>
 The
 <a href="http://www.uniprot.org/uniprot/?query=(accession:P0DOZ7+OR+accession:P58805+OR+accession:P85871+OR+accession:P0DM26+OR+accession:P0DM27)+AND+reviewed:yes">
  5 conopeptides
 </a>
 have been updated in UniProtKB/Swiss-Prot and are publicly available.
</p>
<h2 id="UniProt_website_news">
 UniProt website news
</h2>
<p>
 We have changed our
 <a href="http://www.uniprot.org/blast">
  BLAST
 </a>
 <strong>
  default
 </strong>
 dataset from UniProtKB to
 <strong>
  "Reference proteomes + Swiss-Prot"
 </strong>
 . You can still select UniProtKB or other options under "Target database" in the BLAST submission form.
</p>
<h2 id="UniProtKB_news">
 UniProtKB news
</h2>
<h3 id="Cross_references_to_ABCD">
 Cross-references to ABCD
</h3>
<p>
 Cross-references have been added to the ABCD (AntiBodies Chemically Defined) Database, a manually curated depository of sequenced antibodies.
</p>
<p>
 ABCD is available at
 <a href="https://web.expasy.org/abcd">
  https://web.expasy.org/abcd
 </a>
 .
</p>
<p>
 The format of the explicit links is:
</p>
<table>
 <tr>
  <th>
   Resource abbreviation
  </th>
  <td>
   ABCD
  </td>
 </tr>
 <tr>
  <th>
   Resource identifier
  </th>
  <td>
   UniProtKB accession number
  </td>
 </tr>
</table>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P07766">
  P07766
 </a>
</p>
<p>
 <a href="http://www.uniprot.org/uniprot/?query=database:abcd&amp;sort=score">
  Show all entries having a cross-reference to ABCD.
 </a>
</p>
<h4 id="Text_format">
 Text format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P07766.txt">
  P07766
 </a>
</p>
<pre>DR   ABCD; P07766; -.
</pre>
<h4 id="XML_format">
 XML format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P07766.xml">
  P07766
 </a>
</p>
<pre>&lt;dbReference type="ABCD" id="P07766"/&gt;
</pre>
<h4 id="RDF_format">
 RDF format
</h4>
<p>
 Example:
 <a href="http://www.uniprot.org/uniprot/P07766.ttl">
  P07766
 </a>
</p>
<pre>uniprot:P07766
  rdfs:seeAlso &lt;http://purl.uniprot.org/abcd/P07766&gt; .
&lt;http://purl.uniprot.org/abcd/P07766&gt;
  rdf:type up:Resource ;
  up:database &lt;http://purl.uniprot.org/database/ABCD&gt; .
</pre>
<h3 id="Removal_of_the_cross_references_to_ProDom">
 Removal of the cross-references to ProDom
</h3>
<p>
 Cross-references to ProDom have been removed.
</p>
<h3 id="Changes_to_the__a_href___docs_humdisease__controlled_vocabulary_of_human_diseases__a_">
 Changes to the
 <a href="http://www.uniprot.org/docs/humdisease">
  controlled vocabulary of human diseases
 </a>
</h3>
<p>
 New diseases:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05533">
   Amelogenesis imperfecta 3C
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05511">
   Brain small vessel disease 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05518">
   Cancer, alopecia, pigment dyscrasia, onychodystrophy, and keratoderma
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05548">
   Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05543">
   Charcot-Marie-Tooth disease, axonal, 2EE
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05529">
   Combined oxidative phosphorylation deficiency 38
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05530">
   Combined oxidative phosphorylation deficiency 39
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05510">
   Cone-rod dystrophy and hearing loss 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05544">
   Cryptophthalmos, unilateral or bilateral, isolated
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05545">
   D-lactic aciduria
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05525">
   Deafness, Y-linked 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05519">
   Dyschromatosis universalis hereditaria 1
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05509">
   Epilepsy, idiopathic generalized 15
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05526">
   Epileptic encephalopathy, early infantile, 72
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05527">
   Epileptic encephalopathy, early infantile, 73
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05528">
   Epileptic encephalopathy, early infantile, 74
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05531">
   Facial dysmorphism, hypertrichosis, epilepsy, intellectual and developmental delay, and gingival overgrowth syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05535">
   Fetal akinesia deformation sequence 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05536">
   Fetal akinesia deformation sequence 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05537">
   Fetal akinesia deformation sequence 4
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05517">
   Gastrointestinal ulceration, recurrent, with dysfunctional platelets
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05520">
   Huriez syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05539">
   Immunodeficiency 60
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05546">
   Immunodeficiency 61
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05523">
   Intellectual developmental disorder, autosomal recessive 69
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05524">
   Intellectual developmental disorder, autosomal recessive 70
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05522">
   Intellectual developmental disorder, X-linked 108
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05504">
   Intellectual developmental disorder with abnormal behavior, microcephaly, and short stature
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05547">
   Intellectual developmental disorder with short stature, facial anomalies, and speech defects
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05532">
   Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05506">
   Microcephaly, growth deficiency, seizures, and brain malformations
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05521">
   Mitochondrial myopathy, episodic, with optic atrophy and reversible leukoencephalopathy
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05503">
   Muscular dystrophy, congenital, megaconial type
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05513">
   Myoclonus, familial, 2
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05507">
   Neurodevelopmental disorder and language delay with or without structural brain abnormalities
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05508">
   Neurodevelopmental disorder with central and peripheral motor dysfunction
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05514">
   Neurodevelopmental disorder with microcephaly, epilepsy, and hypomyelination
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05505">
   Polymicrogyria with or without vascular-type Ehlers-Danlos syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05512">
   Short stature, amelogenesis imperfecta, and skeletal dysplasia with scoliosis
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05515">
   Spinocerebellar ataxia, autosomal recessive, 27
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05534">
   Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05541">
   Spondyloepimetaphyseal dysplasia with joint laxity, 3
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05540">
   Spondyloepiphyseal dysplasia, Kondo-Fu type
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05542">
   T-cell lymphoma, subcutaneous panniculitis-like
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05516">
   Turnpenny-Fry syndrome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/diseases/DI-05538">
   Witteveen-Kolk syndrome
  </a>
 </li>
</ul>
<p>
 Modified diseases:
</p>
<ul>
 <li>
  Acyl-CoA dehydrogenase family, member 9, deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01173">
   Mitochondrial complex I deficiency, nuclear type 20
  </a>
 </li>
 <li>
  Alport syndrome, autosomal dominant -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02831">
   Alport syndrome 3, autosomal dominant
  </a>
 </li>
 <li>
  Alport syndrome, autosomal recessive -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00080">
   Alport syndrome 2, autosomal recessive
  </a>
 </li>
 <li>
  Alport syndrome, X-linked -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00082">
   Alport syndrome 1, X-linked
  </a>
 </li>
 <li>
  Bart-Pumphrey syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00172">
   Knuckle pads, leukonychia, and sensorineural deafness
  </a>
 </li>
 <li>
  Capillary malformation-arteriovenous malformation -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01315">
   Capillary malformation-arteriovenous malformation 1
  </a>
 </li>
 <li>
  Congenital disorder of glycosylation with defective fucosylation -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05266">
   Congenital disorder of glycosylation with defective fucosylation 1
  </a>
 </li>
 <li>
  Dementia Lewy body -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01901">
   Dementia, Lewy body
  </a>
 </li>
 <li>
  Dopamine beta-hydroxylase deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01502">
   Orthostatic hypotension 1
  </a>
 </li>
 <li>
  Ectodermal dysplasia, anhidrotic, with immunodeficiency X-linked -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00424">
   Ectodermal dysplasia and immunodeficiency 1
  </a>
 </li>
 <li>
  Ectodermal dysplasia, anhidrotic, with T-cell immunodeficiency autosomal dominant -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00425">
   Ectodermal dysplasia and immunodeficiency 2
  </a>
 </li>
 <li>
  Ectodermal dysplasia, Rapp-Hodgkin type -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00428">
   Rapp-Hodgkin syndrome
  </a>
 </li>
 <li>
  Epidermodysplasia verruciformis -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01531">
   Epidermodysplasia verruciformis 1
  </a>
 </li>
 <li>
  Hyperimmunoglobulin E recurrent infection syndrome, autosomal dominant -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01767">
   Hyper-IgE recurrent infection syndrome 1, autosomal dominant
  </a>
 </li>
 <li>
  Hyperimmunoglobulin E recurrent infection syndrome, autosomal recessive -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02809">
   Hyper-IgE recurrent infection syndrome 2, autosomal recessive
  </a>
 </li>
 <li>
  Hypomagnesemia, seizures, and mental retardation -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04456">
   Hypomagnesemia, seizures, and mental retardation 1
  </a>
 </li>
 <li>
  Jansen metaphyseal chondrodysplasia -&gt;
  <a href="http://www.uniprot.org/diseases/DI-01847">
   Metaphyseal chondrodysplasia, Jansen type
  </a>
 </li>
 <li>
  Lethal arthrogryposis with anterior horn cell disease -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00643">
   Congenital arthrogryposis with anterior horn cell disease
  </a>
 </li>
 <li>
  Marfan lipodystrophy syndrome -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04689">
   Marfanoid-progeroid-lipodystrophy syndrome
  </a>
 </li>
 <li>
  Mental retardation, X-linked 49 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04808">
   Raynaud-Claes syndrome
  </a>
 </li>
 <li>
  Mental retardation, X-linked 61 -&gt;
  <a href="http://www.uniprot.org/diseases/DI-04795">
   Tonne-Kalscheuer syndrome
  </a>
 </li>
 <li>
  Neurodevelopmental disorder with brain, liver, and lung abnormalities -&gt;
  <a href="http://www.uniprot.org/diseases/DI-05269">
   Rajab interstitial lung disease with brain calcifications
  </a>
 </li>
 <li>
  Neuropathy, congenital hypomyelinating or amyelinating -&gt;
  <a href="http://www.uniprot.org/diseases/DI-00358">
   Neuropathy, congenital hypomyelinating, 1, autosomal recessive
  </a>
 </li>
 <li>
  Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02174">
   Polycystic lipomembranous osteodysplasia with sclerosing leukoencephalopathy 1
  </a>
 </li>
 <li>
  Popliteal pterygium syndrome, lethal type -&gt;
  <a href="http://www.uniprot.org/diseases/DI-03375">
   Bartsocas-Papas syndrome
  </a>
 </li>
 <li>
  X-linked hypogammaglobulinemia and isolated growth hormone deficiency -&gt;
  <a href="http://www.uniprot.org/diseases/DI-02446">
   Growth hormone deficiency, isolated, 3, with agammaglobulinemia
  </a>
 </li>
</ul>
<p>
 Deleted diseases
</p>
<ul>
 <li>
  Cardiomyopathy, familial hypertrophic 19
 </li>
 <li>
  Myopathy, centronuclear, 3
 </li>
 <li>
  Parkes Weber syndrome
 </li>
</ul>
<h3 id="Changes_in__a_href___docs_subcell__subcellular_location_controlled_vocabulary__a_">
 Changes in
 <a href="http://www.uniprot.org/docs/subcell">
  subcellular location controlled vocabulary
 </a>
</h3>
<p>
 New subcellular locations:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0510">
   Magnetosome
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0511">
   Magnetosome lumen
  </a>
 </li>
 <li>
  <a href="http://www.uniprot.org/locations/SL-0512">
   Magnetosome membrane
  </a>
 </li>
</ul>
<h3 id="Changes_to__a_href___docs_keywlist__keywords__a_">
 Changes to
 <a href="http://www.uniprot.org/docs/keywlist">
  keywords
 </a>
</h3>
<p>
 New keyword:
</p>
<ul>
 <li>
  <a href="http://www.uniprot.org/keywords/KW-1281">
   Magnetosome
  </a>
 </li>
</ul>